{
  "meta": {
    "title": "Inflammatory_Bowel_Disease",
    "url": "https://brainandscalpel.vercel.app/inflammatory-bowel-disease-c7a837a8.html",
    "scrapedAt": "2025-11-30T11:20:50.767Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute transmural inflammation</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic transmural inflammation</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute full thickness inflammation</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic full thickness inflammation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which type of pathological change is seen in Crohn's disease?</span></p>",
      "unique_key": "DT1189490",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189490,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Crohn Disease</strong></p>\n<ul>\n<li>Crohn disease is a <strong>chronic, transmural inflammatory disease of the gastrointestinal tract </strong>for which the definitive cause is unknown, although a combination of genetic and environmental factors has been implicated.</li>\n<li>Crohn disease <strong>can involve any part of the alimentary tract from the mouth to the anus </strong>but most commonly affects the <strong>small intestine and colon.</strong></li>\n<li>The most common clinical manifestations are <strong>abdominal pain, diarrhoea, and weight loss.</strong></li>\n<li>Crohn disease can be complicated by intestinal obstruction or localized perforation with fistula formation.</li>\n<li>Medical and surgical treatments are palliative; however, operative therapy can provide effective symptomatic relief for patients with complications from Crohn disease and produces a reasonable long-term benefit.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1258</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal pain</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleeding per rectum</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Diarrhoea</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight loss</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not the common manifestation seen in Crohn's disease?</span></p>",
      "unique_key": "DT1189498",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189498,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Crohn Disease</strong></p>\n<ul>\n<li>Crohn disease is a chronic, transmural inflammatory disease of the gastrointestinal tract for which the definitive cause is unknown, although a combination of genetic and environmental factors has been implicated.</li>\n<li>Crohn disease can involve any part of the alimentary tract from the mouth to the anus but most commonly affects the small intestine and colon.</li>\n<li>The most common clinical manifestations are abdominal pain, diarrhoea, and weight loss.</li>\n<li>Crohn disease can be complicated by intestinal obstruction or localized perforation with fistula formation.</li>\n<li>Medical and surgical treatments are palliative; however, operative therapy can provide effective symptomatic relief for patients with complications from Crohn disease and produces a reasonable long-term benefit.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1258</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">0-10 years</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">20-30 years</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">30-40 years</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">40-50 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which age group patients are primarily affected by Crohn's disease?</span></p>",
      "unique_key": "DT1189502",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Incidence and Epidemiology</strong></p>\n<ul>\n<li><strong>Crohn disease primarily attacks young adults in the second and third decades of life</strong>. However, a bimodal distribution is apparent, with a <strong>second smaller peak occurring in the sixth decade of life</strong>.</li>\n<li>Crohn disease is more common in urban dwellers, and although earlier reports suggested a somewhat higher female predominance, the two genders are affected equally.</li>\n<li>The risk for development of Crohn disease is about twice as high in <strong>smokers </strong>as in non-smokers.</li>\n<li>Several studies indicate an increased incidence of Crohn disease in women using oral contraceptives; however, more recent studies have shown no differences.</li>\n<li>Certain ethnic groups, particularly Ashkenazi Jews, have a two- to four-fold higher incidence of Crohn disease than age- and gender-matched control subjects</li>\n<li>Individuals born during the spring months (e.g., April to June) are more likely to develop Crohn disease;</li>\n<li>there also appears to be a north-south gradient worldwide, and populations in higher latitudes have higher incidence rates than populations in lower latitudes. There is a strong familial association, with the risk for development of Crohn disease increased about 30-fold in siblings and 14- to 15-fold for all first-degree relatives.</li>\n<li>Other analyses that support a genetic role for Crohn disease have shown a concordance rate of only 4% in dizygotic twins but a 20% to 50% rate in monozygotic twins.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1259</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">African American</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Caucasians</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Ashkenazi jews</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Indians</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which group of population shows increased risk of Crohn's disease?</span></p>",
      "unique_key": "DT1189508",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Incidence and Epidemiology</strong></p>\n<ul>\n<li>Crohn disease primarily attacks young adults in the second and third decades of life.</li>\n<li>However, a bimodal distribution is apparent, with a second smaller peak occurring in the sixth decade of life.</li>\n<li>Crohn disease is more common in urban dwellers, and although earlier reports suggested a some what higher female predominance, the two genders are affected The risk for development of Crohn disease is about twice as high in smokers as in non-smokers.</li>\n<li>Worldwide, Crohn disease is relatively uncommon in African Americans; however, in the United States, the rates of Crohn disease in African Americans is similar to that seen in Caucasians.</li>\n<li>Certain ethnic groups, particularly <strong>Ashkenazi Jews, have a two- to four-fold higher incidence of Crohn disease than age- and gender-matched control subjects.</strong></li>\n<li>Individuals born <strong>duri</strong>ng the spring months (e.g., April to June) are more likely to develop Crohn disease;</li>\n<li>there also appears to be a north-south gradient worldwide, and populations in higher latitudes have higher incidence rates than populations in lower latitudes.</li>\n</ul>\n<p><strong>Reference:</strong> Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1259</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">More commonly seen in urban dwellers</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">More commonly seen in non-smokers</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">More commonly inherited in monozygotic twins</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">More commonly seen in high latitudes population</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statements is false for incidence of Crohn's disease?</span></p>",
      "unique_key": "DT1189510",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189510,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Incidence and Epidemiology</strong></p>\n<ul>\n<li>Crohn disease primarily attacks young adults in the second and third decades of life. However, a bimodal distribution is apparent, with a second smaller peak occurring in the sixth decade of life.</li>\n<li>Crohn disease is more common in <strong>urban dwellers, </strong>and although earlier reports suggested a somewhat higher female predominance, the two genders are affected equally.</li>\n<li>The risk for development of Crohn disease is about <strong>twice as high in smokers </strong>as in non-smokers.</li>\n<li>Certain ethnic groups, particularly Ashkenazi Jews, have a two- to four-fold higher incidence of Crohn disease than age- and gender-matched control subjects.</li>\n<li>Individuals born during the spring months (e.g., April to June) are more likely to develop Crohn disease;</li>\n<li>there also appears to be a north-south gradient worldwide, and <strong>populations in higher latitudes have higher incidence rates than populations in lower latitudes</strong>.</li>\n<li>There is a strong familial association, with the risk for development of Crohn disease increased about 30-fold in siblings and 14- to 15-fold for all first-degree relatives.</li>\n<li>Other analyses that support a genetic role for Crohn disease have shown a concordance rate of only 4% in dizygotic twins but a 20% to 50% rate in monozygotic twins.</li>\n<li>More recent studies evaluating twins with and without Crohn disease have used advanced genomic and proteomic techniques to show that intestinal microflora and epigenetic changes induced by environmental factors play an important role in disease development and progression in genetically susceptible individuals.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21st, Pg: 1259</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium paratuberculosis</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">E. coli</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical mycobacteria</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Salmonella paratyphi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following microbial organism is not associated with the incidence of Crohn's disease?</span></p>",
      "unique_key": "DT1189519",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189519,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Infectious agents.</strong></p>\n<ul>\n<li>Although a number of infectious agents have been proposed as potential causes of Crohn disease, the two that have received the most attention are mycobacterial infections, particularly <strong><em>Mycobacterium paratuberculosis </em>and enteroadherent <em>coli</em>.</strong></li>\n<li>The existence of atypical mycobacteria as a cause for Crohn disease was proposed by Dalziel in 1913. Subsequent studies using polymerase chain reaction (PCR) techniques have confirmed the presence of mycobacteria in intestinal samples of patients with Crohn disease.</li>\n<li>Transplantation of tissue from patients with Crohn disease has resulted in <strong>ileitis</strong>, but antimicrobial therapy directed against mycobacteria has not been effective in ameliorating the established disease process.</li>\n<li>Strains of enteroadherent <em>coli </em>are in higher abundance in patients with Crohn disease compared with the general population based on PCR analysis.</li>\n<li>More recent studies have used fluorescent in situ hybridization to demonstrate <strong>increased numbers of <em>coli </em>in the lamina propria of patients with active Crohn disease </strong>compared with those with inactive disease.</li>\n<li>Furthermore, an increased number of <em>coli </em>has been associated with a shorter time before relapse of the disease.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1259</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin - 1</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin - 2</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin - 6</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">TNF - alpha</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following cytokines is not a contributing factor in intestinal inflammatory disease?</span></p>",
      "unique_key": "DT1189523",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189523,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Immunologic factors.</strong></p>\n<ul>\n<li>Humoral and cell-mediated immune reactions directed againstintestinal cells in Crohn disease suggest an autoimmune phenomenon.</li>\n<li>Attention has focused on the role of cytokines, such as <strong>interleukin (IL)-1, IL-2, IL- 8, and TNF-&alpha;, </strong>as contributing factors in the intestinal inflammatory response.</li>\n<li>The role of the immune response remains controversial in Crohn disease and may represent an effect of the disease process rather than an actual cause.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1259</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Smoking</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral contraceptives</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased dietary fibres</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following environmental factors is not associated with the increased risk in incidence of Crohn's disease?</span></p>",
      "unique_key": "DT1189528",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Environmental factors.</strong></p>\n<ul>\n<li>Low-risk countries in Asia that have adopted a more Western lifestyle have noted a significant rise in the incidence of Crohn disease.</li>\n<li><strong>Smoking is the single largest environment factor, </strong>with a two fold increase in risk of Crohn disease.</li>\n<li>Single nucleotide polymorphisms associated with smoking increase the risk of Crohn disease in smokers, identifying a genetic disposition for an environmental risk factor.</li>\n<li>In addition, other factors that increase the risk of Crohn disease include <strong>medications </strong>(oral contraceptives, aspirin, nonsteroidal anti-inflammatory drugs [NSAIDs]), <strong>decreased dietary fiber</strong>, and <strong>increase fat intake</strong>.</li>\n<li>In addition, dysbiosis with a <strong>decrease in intraluminal <em>Bacteroides </em>and <em>Firmicutes </em>and an increase in <em>Gammaproteobacteria </em>and <em>Actinobacteria </em>are associated with higher risk.</strong></li>\n<li>Specifically, an increase of mucosal- adherent-invasive <em>coli </em>survive within macrophages and induce higher TNF-&alpha; production. There are numerous studies evaluating the therapeutic benefits of microbiota manipulation.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1259</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">NOD2</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">MHC</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">CARD15</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">PTEN</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following gene is not associated with inflammatory bowel disease?</span></p>",
      "unique_key": "DT1189531",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189531,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Genetic factors:</strong></p>\n<ul>\n<li>Genetic factors play an important role in the pathogenesis of Crohn disease because the single strongest risk factor for development of disease is having a first-degree relative with Crohn disease.</li>\n<li>The genes with the strongest and most frequently replicated associations with Crohn disease are <strong><em>NOD2</em>, <em>MHC</em>, and <em>MST1 </em>3p21</strong>.</li>\n<li>Putative inflammatory bowel disease loci have been identified on chromosomes 16q, 5q, 19p, 7q, and 3p.</li>\n<li><strong>The most important gene in Crohn disease development is <em>NOD2</em></strong>. The <em>NOD2 </em>gene is associated with a decreased expression of antimicrobial peptides by Paneth Heterozygosity of one <em>NOD2 </em>variant confers a 2- to 4-fold increase in risk of Crohn disease, while homozygosity confers a 17- to 40-fold increase in risk. In addition, <em>NOD2 </em>has been identified as a genetic predictor of ileal disease, ileal stenosis, fistula, and Crohn-related surgery.</li>\n<li>Another gene, <strong><em>CARD15</em>, leads to impaired activation of the transcription factor nuclear factor kappa B (NF-&kappa;B) </strong>and also specifically codes for a protein expressed in monocytes, macrophages, dendritic cells, epithelial cells, and Paneth cells.</li>\n<li><strong><em>CARD15 </em></strong><strong>is</strong> also helpful in distinguishing Crohn disease from ulcerative colitis as it is more <strong>strongly associated with Crohn disease</strong>, especially in patients of northern European descent.</li>\n<li>The <strong><em>FHIT </em>gene located on 3p14.2 has been identified as a tumor suppressor gene and is suggested to play a role in the pathogenesis of Crohn disease</strong> as well as in the development and progression of Crohn disease-related cancers.</li>\n<li>A complex cellular and molecular crosstalk occurs between the genes <em>NOD2/CARD15 </em>and the autophagy gene <em>ATG16L1</em>, which is associated with a synergistic increase in earlier onset and disease severity.</li>\n</ul>\n<p><strong>Reference:</strong> Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1259</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Enteritis</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Crohn's disease</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid ulcers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following disease shows cobblestone appearance of the intestine?</span></p>",
      "unique_key": "DT1189537",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189537,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Gross pathologic features.</strong></p>\n<ul>\n<li>At exploration, <strong>thickened Gray pink or dull purple-red loops of bowel </strong>are noted, with areas of <strong>thick gray-white exudate or fibrosis of the serosa.</strong></li>\n<li>Areas of diseased bowel separated by areas of grossly appearing normal bowel, called <strong><em>skip areas</em></strong>, are commonly encountered.</li>\n<li>A striking finding of Crohn disease is the presence of extensive fat wrapping caused by the circumferential growth of the mesenteric fat around the bowel wall, also known as <strong>creeping fat.</strong></li>\n<li>As the disease progresses, the <strong>bowel wall becomes increasingly thickened, firm, rubbery, and almost incompressible.</strong></li>\n<li>The uninvolved proximal bowel may be dilated secondary to obstruction of the diseased Involved segments often are adherent to adjacent intestinal loops or other viscera, with internal fistulas common in these areas.</li>\n<li>The mesentery of the involved segment is usually thickened, with <strong>enlarged lymph nodes </strong>often noted.</li>\n<li>On opening of the bowel, the <strong>earliest gross pathologic lesion is a superficial aphthous ulcer noted in the mucosa</strong>.</li>\n<li>With increasing disease progression, the ulceration becomes pronounced, and complete; <strong>transmural inflammation</strong> results.</li>\n<li>The ulcers are characteristically linear and may coalesce to produce transverse sinuses with islands of normal mucosa in between, thus giving the characteristic cobblestone appearance.</li>\n</ul>\n<p><strong>Reference:</strong> Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1260</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Occurrence of skip lesion</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Occurrence of incompressible intestine</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Superficial aphthous ulcer in mucosa</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobblestone appearance of intestine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the earliest gross pathological feature in Crohn's disease?</span></p>",
      "unique_key": "DT1189540",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189540,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Gross pathologic features.</strong></p>\n<ul>\n<li>At exploration, thickened Gray pink or dull purple-red loops of bowel are noted, with areas of thick gray-white exudate or fibrosis of the serosa.</li>\n<li>Areas of diseased bowel separated by areas of grossly appearing normal bowel, called <strong><em>skip areas</em>, </strong> are commonly encountered.</li>\n<li>A striking finding of Crohn disease is the presence of extensive fat wrapping caused by the circumferential growth of the mesenteric fat around the bowel wall, also known as <strong>creeping fat.</strong></li>\n<li>As the disease progresses, the bowel wall becomes increasingly thickened, firm, rubbery, and almost incompressible.</li>\n<li>The uninvolved proximal bowel may be dilated secondary to obstruction of the diseased segment.</li>\n<li>Involved segments often are adherent to adjacent intestinal loops or other viscera, with internal fistulas common in these areas.</li>\n<li>The mesentery of the involved segment is usually thickened, with enlarged lymph nodes often noted.</li>\n<li>On opening of the bowel, the <strong>earliest gross pathologic lesion is a superficial aphthous ulcer noted in the mucosa</strong>.</li>\n<li>With increasing disease progression, the ulceration becomes pronounced, and complete transmural inflammation results.</li>\n<li>The ulcers are characteristically linear and may coalesce to produce transverse sinuses with islands of normal mucosa in between, thus giving the characteristic cobblestone appearance.</li>\n</ul>\n<p><strong>Reference:</strong> Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1260</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic full thickness inflammation</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Infiltration of macrophages</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Noncaseating granulomas with Langerhans giant cells</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Infiltration of neutrophils</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the characteristic histological lesion in Crohn's disease?</span></p>",
      "unique_key": "DT1189547",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189547,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Microscopic features.</strong></p>\n<ul>\n<li>Mucosal and submucosal Edema may be noted microscopically before any gross changes.</li>\n<li>A chronic inflammatory infiltrate appears in the mucosa and submucosa and extends transmurally.</li>\n<li>This inflammatory reaction is characterized by extensive <strong>Edema, hyperaemia, lymphangiectasia, intense infiltration of mononuclear cells, and lymphoid hyperplasia.</strong></li>\n<li>Characteristic histologic lesions of Crohn disease are noncaseating granulomas with Langerhans giant cells.</li>\n<li>Granulomas appear later in the course and are found in the wall of the bowel or in regional lymph nodes in 60% to 70% of patients.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1261</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal pain</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic diarrhoea</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaise</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight loss</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the first symptom in the patient of Crohn's disease?</span></p>",
      "unique_key": "DT1189553",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189553,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Crohn disease can occur at any age, but the typical patient is a young adult in the second or third decade of life.</li>\n<li>The onset of disease is often insidious, with a slow and protracted course.</li>\n<li>Characteristically, there are symptomatic periods of abdominal pain and diarrhoea interspersed with asymptomatic periods of varying lengths.</li>\n<li>With time, the symptomatic periods gradually become more frequent, more severe, and longer lasting.</li>\n<li>The <strong>most common symptom of Crohn disease is chronic diarrhoea, followed by intermittent and colicky abdominal pain</strong>, most commonly noted in the lower abdomen.</li>\n<li>The pain, however, may be more severe and localized in the right lower quadrant and may mimic the signs and symptoms of acute appendicitis.</li>\n<li>In contrast to ulcerative colitis, patients with Crohn disease typically have fewer bowel movements, and the stools rarely contain mucus, pus, or blood.</li>\n<li>Systemic nonspecific symptoms include a <strong>low-grade fever </strong>present in about one third of the patients, <strong>weight loss, loss of strength, and malaise.</strong></li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1261</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Jejunum</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileum</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Duodenum</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Colon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which part of the gastrointestinal tract cancer occurs due to the Crohn's disease?</span></p>",
      "unique_key": "DT1189558",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Long-standing Crohn disease predisposes to cancer of the small intestine and colon.</li>\n<li>These <strong>carcinomas typically arise at sites of chronic disease and more commonly occur in the ileum </strong>as a result of the chronic inflammation of the mucosa.</li>\n<li>Most are not detected until in advanced stages, and the prognosis is poor.</li>\n<li>Although the relative risk for small bowel cancer in Crohn disease is approximately 100-fold, the absolute risk is still small.</li>\n<li>Of greater concern is the development of colorectal cancer in patients with colonic involvement and a long duration of disease.</li>\n<li>Dysplasia is the putative precursor lesion for Crohn disease-associated cancer. Patients with long-standing Crohn disease should have an equally aggressive colonoscopic surveillance regimen as patients with extensive ulcerative colitis.</li>\n<li>Small bowel adenocarcinoma associated with Crohn disease has an aggressive behavior and a strong probability of extracellular mucin.</li>\n<li>In surgical specimens from patients with Crohn disease, mucinous-appearing anal fistulas and ileal areas of adhesion/retraction should always be closely examined by a pathologist to evaluate for dysplasia or malignancy.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1261</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythema nodosum</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Uveitis</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudocyst pancreas</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not the extraintestinal manifestation of Crohn's disease?</span></p>",
      "unique_key": "DT1189562",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Extraintestinal manifestations of Crohn disease may be present in 30% of patients.</li>\n<li>The most common symptoms are skin lesions, which include <strong>erythema nodosum and pyoderma gangrenosum, arthritis and arthralgias, uveitis and iritis, hepatitis, pericholangitis, and aphthous stomatitis</strong>.</li>\n<li>In addition, <strong>amyloidosis, pancreatitis, and nephrotic syndrome&nbsp;</strong>may occur in these patients.</li>\n<li>These symptoms may precede, accompany, or appear independently of the underlying bowel disease.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1261</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Stricture</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Abscess</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignancy</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Fistula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not the perianal manifestation of Crohn's disease?</span></p>",
      "unique_key": "DT1189566",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189566,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Perianal disease <strong>(fissure, fistula, stricture, or abscess) </strong>is common and occurs in 25% of patients with Crohn disease limited to the small intestine, 41% of patients with ileocolitis, and 48% of patients with colonic involvement alone.</li>\n<li>Perianal disease may be the sole presenting feature in 5% of patients and may precede the onset of intestinal disease by months or even years.</li>\n<li>Crohn disease should be suspected in any patient with multiple, chronic perianal fistulas.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21st, Pg: 1261</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Inflammation</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Perforation</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Infection</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is the main intestinal complication of Crohn's disease?</span></p>",
      "unique_key": "DT1189569",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Clinically, Crohn disease is often classified on the basis of age at onset, behavior, and site of origin.</li>\n<li>The <strong>Montreal Classification </strong>divides all patients into distinct categories based on <strong>symptom onset </strong>(before or after the age of 40 years), <strong>disease behaviour </strong>(nonstricturing/nonpenetrating, stricturing, or penetrating), and <strong>disease site </strong>(terminal ileum, colon, ileocolonic, upper gastrointestinal tract).</li>\n<li>This classification was developed to provide a reproducible staging of the disease, to help predict remission and relapse, and to direct therapy.</li>\n<li>The main intestinal complications of Crohn disease include obstruction and perforation.</li>\n<li>Obstruction can occur as a manifestation of an acute exacerbation of active disease or as the result of <strong>chronic fibrosing lesions</strong>, which eventually narrow the lumen of the bowel, producing partial or near-complete obstruction.</li>\n<li>Free perforations into the peritoneal cavity leading to a <strong>generalized peritonitis </strong>can occur in patients with Crohn disease, but this presentation is rare.</li>\n<li>More commonly, fistulas occur between the sites of perforation and adjacent organs, such as loops of small and large intestine, urinary bladder, vagina, stomach, and sometimes the skin, usually at the site of a previous laparotomy.</li>\n<li>Localized abscesses can occur near the sites of Patients with Crohn colitis may develop toxic megacolon and present with a marked colonic dilation, abdominal tenderness, fever, and leukocytosis.</li>\n<li>Bleeding is typically indolent and chronic, but massive gastrointestinal bleeding can occasionally occur, particularly in duodenal Crohn disease associated with chronic ulcer formation.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1261</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">ANCA</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">ASCA</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti - Cbir 1</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">OmpC - IgG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which serological marker is useful in differentiating Crohn's disease from ulcerative colitis?</span></p>",
      "unique_key": "DT1189576",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189576,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Laboratory.</strong></p>\n<ul>\n<li>Serologic markers may useful in the diagnosis of Crohn disease. In particular, perinuclear antineutrophil cytoplasmic antibody (and its target proteins bactericidal/permeability increasing protein [BPI], lactoferrin, cathepsin G and elastase), anti-<em>Saccharomyces cerevisiae </em>antibody (ASCA), outer membrane porin of flagellin (anti-CBir1), and outer membrane porin of <em>coli </em>(OmpC-IgG) can predict the development of inflammatory bowel disease even in patients thought to be at low risk for development of disease.</li>\n<li><strong>ASCA is also useful in differentiating Crohn disease from ulcerative colitis </strong>as well as playing a role in determining patients who will require surgery in the future.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1262</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Crohn's disease</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Enteritis</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocaecal tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following disease shows comb's sign on CT enterography?</span></p>",
      "unique_key": "DT1189583",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Non-invasive inflammatory markers, historically <strong>C-reactive protein and erythrocyte sedimentation rate</strong>, were used to aid in the initial diagnosis, to rule out exacerbations, to monitor response to systemic therapy, and to predict relapse; however, these markers were generally nonspecific and have largely been abandoned.</li>\n<li><strong>Stool lactoferrin, </strong>an iron-binding protein in the secretory granules of neutrophils, and <strong>fecal calprotectin</strong>, a protein with antimicrobial properties released by squamous cells in response to inflammation, are inflammatory markers specific to the intestine that have shown promising results for the detection and surveillance of Crohn disease.</li>\n<li>A prospective study showed that both <strong>calprotectin and lactoferrin </strong>levels correlate well with CT enterography (CTE) images of small bowel inflammation (<strong>mucosal irregularity, hyper density, stenosis, prestenotic dilation and mesenteric hypervascularity [i.e., comb sign]</strong>).</li>\n<li>Fecal calprotectin levels greater than 140 ng/mL, predicted small bowel inflammation with a sensitivity of 69% and a specificity of 82%. Similarly, fecal lactoferrin (&gt;6 ng/mL) predicted small bowel inflammation with a sensitivity of 69% and a specificity of 79%.</li>\n<li>Fecal calprotectin is associated with elevated C-reactive protein and erythrocyte sedimentation rate levels, whereas fecal lactoferrin is only associated with elevated C- reactive protein levels.</li>\n<li>Together, these findings identify fecal calprotectin and lactoferrin as helpful screening tools for detecting early small bowel Crohn disease.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1263</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Crohn's disease</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Enteritis</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Appendicitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following diseases shows Kantor string sign on barium enema study?</span></p>",
      "unique_key": "DT1189589",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189589,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Radiology.</strong></p>\n<ul>\n<li>CTE or magnetic resonance enterography (MRE) are often used as the initial assessment of Crohn disease to complement direct ileocolonoscopy.</li>\n<li>Imaging studies can provide information regarding severity of inflammation, length, and focality and identify complications (e.g., obstruction or fistula).</li>\n<li>In addition, these studies support surgical planning and the evaluation of response to medical therapy.</li>\n<li>Previously, barium enema was commonly used to identify features of Crohn For example, <strong>long lengths of narrowed terminal ileum (Kantor string sign</strong>) may be present with long-standing disease.</li>\n<li>Segmental and irregular patterns of bowel involvement may be Fistulas between adjacent bowel loops and organs may be apparent</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1263</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\"> CT enterography</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">MR enterography</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolonoscopy with biopsy</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium enema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the gold standard test for the diagnosis of Crohn's disease?</span></p>",
      "unique_key": "DT1189602",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189602,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Endoscopy.</em></strong></p>\n<ul>\n<li>Ileocolonoscopy with biopsies of the terminal ileum are the gold standard for the diagnosis of Crohn disease.</li>\n<li>When the colon is involved, <strong>sigmoidoscopy or colonoscopy </strong>may reveal characteristic aphthous ulcers with granularity and a normal-appearing surrounding</li>\n<li>Intubation of the ileocecal valve during colonoscopy allows examination and biopsy of the terminal ileum but fails to evaluate other segments of the small</li>\n<li>With more progressive and severe disease, the ulcerations involve progressively more of the bowel lumen, and it may be difficult to distinguish Crohn disease from ulcerative</li>\n<li>However, the presence of discrete ulcers and cobblestoning as well as the discontinuous segments of involved bowel favors a diagnosis of Crohn</li>\n<li>Endoscopic advances that allow better evaluation of the small intestine include <strong>singleballoon enteroscopy, double-balloon enteroscopy, and spiral enteroscopy; </strong>the most well-established technique is doubleballoon enteroscopy, which allows increased enteral intubation (240-360 cm) compared with push enteroscopy (90-150 cm) or ileocolonoscopy (50-80 cm).</li>\n<li>Limitations include specialized examiner skills and equipment, prolonged procedure times, and a 1% risk of complications (e.g., pancreatitis, perforation, or bleeding).</li>\n<li>After the diagnosis is confirmed, the Crohn Disease Endoscopic Index of Severity (CDEIS) or the Simple Endoscopic Score for Crohn Disease (SES-CD) is used to define extent of disease and severity.</li>\n</ul>\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1264</p>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileum</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Jejunum</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectum</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Ascending </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the most common site of occurrence of ulcerative colitis?</span></p>",
      "unique_key": "DT1189616",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189616,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>In most cases, Crohn disease of the colon can be readily distinguished from ulcerative colitis; however, in 5% to 10% of patients, the delineation between Crohn disease and ulcerative colitis may be difficult if not impossible to make.</li>\r\n<li><strong>Ulcerative colitis almost always involves the rectum most severely</strong>, with lessening inflammation <strong>from the rectum to the ileocolic area</strong>.</li>\r\n<li>In contrast, Crohn disease may be worse on the right side of the colon than on the left side, and sometimes the rectum is spared.</li>\r\n<li>Ulcerative colitis also demonstrates <strong>continuous involvement </strong>from rectum to proximal segments, whereas Crohn disease is segmental.</li>\r\n<li>Although ulcerative colitis involves the mucosa of the large intestine, it does not extend deep into the wall of the bowel as does Crohn disease.</li>\r\n<li><strong>Bleeding is a more common symptom in ulcerative colitis.</strong></li>\r\n<li>Perianal involvement and rectovaginal fistulas are unusual in ulcerative colitis but are more common in Crohn disease.</li>\r\n<li>Other endoscopic features of Crohn disease are skip lesions, asymmetric involvement of bowel, and the cobblestone appearance that results from ulcerations interspersed with islands of oedematous mucosa.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1264</p>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Collar button type of ulcers are seen</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcers are superficial</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Anal complaints are common</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectal bleeding is always present</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statements is false for ulcerative colitis?</span></p>",
      "unique_key": "DT1189617",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189617,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;  \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240325b58a74ca-b633-4526-bae9-a97a0459a923.jpg\"><p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1265</p>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Ozanimod</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Tofacitinib</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Mongersen</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">MadCAM-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following drugs is JAK3 pathway inhibitor drug?</span></p>",
      "unique_key": "DT1189618",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Other innovative therapies such as <strong>MadCAM-1 </strong>([mucosal addressin cell adhesion molecule 1] inhibitor), <strong>tofacitinib (JAK3 pathway inhibitor</strong>), <strong>mongersen </strong>(SMAD7 inhibitor), and <strong>ozanimod </strong>(S1P1 inhibitor) are all currently under phase II/III clinical trials.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1265</p>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Beneficial in moderate to severe Crohn's disease</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Useful in maintenance therapy</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic treatment causes osteoporosis</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\"> Bisphosphonate therapy is started with</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statement is false for prednisolone therapy in Crohn's disease?</span></p>",
      "unique_key": "DT1189619",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189619,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>An alternative corticosteroid, prednisone, can be beneficial in <strong>moderate to severe Crohn disease.</strong></li>\r\n<li>Prednisone is <strong>not ideal for maintenance therapy </strong>as more than 50% of patients, particularly smokers, treated with corticosteroids become \"steroid dependent,\" and chronic treatment is associated with osteoporosis and increased rates of Crohn disease relapse.</li>\r\n<li>Patients with moderate to severe disease should be treated with high-dose (40-60 mg daily) prednisone until resolution of symptoms and resumption of weight gain.</li>\r\n<li>Parenteral corticosteroids are indicated for patients with severe disease once the presence of an abscess has been Steroids should be tapered once the patient experiences clinical improvement.</li>\r\n<li>Currently, there are no standards for corticosteroid taper, but doses are generally tapered by 5 to 10 mg/ week until 20 mg, and then by 2.5 to 5 mg weekly until cessation.</li>\r\n<li>Dual-energy x-ray absorptiometry scan, <strong>calcium and vitamin D supplementation, and consideration of bisphosphonate therapy are warranted </strong>once corticosteroid therapy is initiated to identify baseline bone density and to prevent steroid-induced loss of bone mineral density.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1266</p>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifaximin</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following antibiotics is not useful in the treatment of Crohn's disease?</span></p>",
      "unique_key": "DT1189620",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Antibiotics.</strong></p>\r\n<ul>\r\n<li>Certain antibiotics were found to be effective as a primary therapy for Crohn disease.</li>\r\n<li>Promising results were initially reported for <strong>metronidazole</strong>, but later studies determined that it was <strong>no more effective than placebo </strong>for inducing remission.</li>\r\n<li>Other antibiotics that have been used with varying success include <strong>ciprofloxacin, rifaximin, clofazimine, ethambutol, isoniazid, and rifabutin.</strong></li>\r\n<li>Antibiotic therapy has a clear role in the septic complications associated with Crohn disease and is beneficial in perianal disease.</li>\r\n<li>The mechanism of action of antibiotics in Crohn disease is unclear, and side effects of these antibiotics preclude their Longterm use.</li>\r\n<li>Therefore, antibiotics may play an adjunctive role in the treatment of Crohn disease and, in selected patients, may be useful in treating perianal disease, enterocutaneous fistulas, or active colonic disease but should not be used in maintenance therapy or to induce remission.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>s</sup>t, Pg: 1266</p>",
      "correct_choice_id": 254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Azathioprine</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclosporine</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">6-mercaptopurine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following immunosuppressive agent is useful in induction and maintenance therapy in Crohn's disease?</span></p>",
      "unique_key": "DT1189621",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189621,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>The immunosuppressive agents <strong>AZT, 6-MP, and MTX </strong>are effective in maintenance therapy and for the treatment of moderate to severe Crohn disease.</li>\r\n<li>AZT and 6-MP are effective for maintaining steroid-induced remission, and <strong>weekly IV MTX is effective for both induction and maintenance therapy</strong>.</li>\r\n<li>Because of the slow onset of action of immunosuppressive agents and to prevent flares, steroids are needed for induction and continued until the transition to immunosuppressive agents is complete.</li>\r\n<li>Despite their potential toxicity, these drugs have proved to be relatively safe in patients with Crohn disease; the most common side effects are <strong>pancreatitis, hepatitis, fever, and rash</strong>.</li>\r\n<li>The more disconcerting complications of immunosuppressants include <strong>chronic liver disease, bone marrow suppression, and the potential for malignant transformation</strong>.</li>\r\n<li>Genetic polymorphisms for thiopurine methyltransferase (TPMT), which is the primary enzyme that metabolizes AZT and 6-MP, have been identified and suggested for use to regulate therapy according to the measurement of their metabolites (6- thioguanine nucleotides).</li>\r\n<li>MTX also has side effects of hepatotoxicity and can cause myelosuppression and should not be used in pregnant women.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1266</p>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Infliximab</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Adalimumab</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Certolizumab</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\"> Etanercept</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following anti-TNF therapy agent is used in pregnant women for the treatment of Crohn's disease?</span></p>",
      "unique_key": "DT1189624",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189624,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Anti-TNF therapy.</strong></p>\r\n<ul>\r\n<li>The introduction of anti-TNF therapy for Crohn disease was considered a breakthrough in medical management.</li>\r\n<li>The first anti-TNF agent introduced was <strong>infliximab</strong>, a chimeric monoclonal antibody to TNF-&alpha;.</li>\r\n<li>Infliximab is efficacious and safe as a monotherapy in the treatment of <strong>moderate to severe Crohn disease and effective both an induction and maintenance agent</strong>.</li>\r\n<li>Multiple studies demonstrated that treatment with infliximab results in perineal fistula closure in approximately two thirds of patients.</li>\r\n<li>Other FDA-approved TNF antagonists include <strong>adalimumab </strong>(humanized IgG1 monoclonal antibody), which is an effective maintenance agent that can be self- administered, and <strong>certolizumab (humanized antibody fragment), which is ideal in pregnant and nursing women </strong>as it is linked to a polyethylene glycol moiety and does not cross the placenta and is not excreted in breast milk.</li>\r\n<li>Safety profiles for these three anti-TNF medications are There is an increased risk for tuberculosis reactivation, invasive fungal and other opportunistic infections, demyelinating central nervous system lesions, activation of latent multiple sclerosis, exacerbation of congestive heart failure, and concerns for increased risk of melanoma.</li>\r\n<li>Patients who develop a flare while on anti-TNF agents require measurement of serum drug concentrations and antidrug antibodies (antibodies binding to competitive and non-competitive sites to inhibit drug function).</li>\r\n<li>Measured levels would indicate the need to increase dosage (if low drug concentration and low antibodies), switch to another anti-TNF agent (high antidrug antibodies), or switch to another drug class (normal drug concentration).</li>\r\n<li>Due to the potential for immunogenicity of monoclonal antibodies, the combination of an anti-TNF agent and an immunosuppressive provides optimal drug levels and low antidrug antibodies</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1266</p>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Natalizumab</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\"> Ustekinumab</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\"> Vedolizumab</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Infliximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following monoclonal antibody agent binds to &alpha;4&beta;7 integrin molecule?</span></p>",
      "unique_key": "DT1189625",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189625,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Novel therapies.</strong></p>\r\n<ul>\r\n<li>Other therapeutic agents for Crohn disease include leukocyte trafficking inhibitors, interleukin inhibitors, and antibodies to antiadhesion molecule.</li>\r\n<li>These agents are often used if the patient has failed or is unable to tolerate anti-TNF therapy.</li>\r\n<li><strong>Natalizumab</strong>, a recombinant humanized monoclonal antibody against &alpha;4 integrin, showed effectiveness in the induction and maintenance of remission in patients with active Crohn disease.</li>\r\n<li>Similarly, <strong>vedolizumab is a humanized monoclonal antibody that specifically binds to &alpha;4&beta;7 integrin and blocks its interaction with MadCAM-1; </strong>this action inhibits the translocation of memory T lymphocytes into inflamed gastrointestinal parenchymal tissues.</li>\r\n<li>Vedolizumab can be used for induction of remission, but it has a very slow onset of Because MadCAM-1 is preferentially expressed on blood vessels in the gastrointestinal tract, vedolizumab is more gut specific and therefore a more targeted form of immunosuppression.</li>\r\n<li>Also, vedolizumab prevents the gastrointestinal mucosal or transmural inflammation without the nonspecific neurologic side effects seen in less selective &alpha;4 integrin inhibitors, such as natalizumab.</li>\r\n<li>Ustekinumab is a humanized IgG1 monoclonal antibody that inhibits IL-12/23 through targeting of a shared p40 subunit. In two large trials, it was shown to be effective in severe Crohn disease that is refractory to anti-TNF therapies with similar efficacy.</li>\r\n<li>Compounds are also being evaluated that block certain signalling pathways (e.g., NF- &kappa;B, mitogen-activated protein kinases, and peroxisome proliferator-activated receptor-&gamma;) in limited studies. Some compounds have shown clinical improvement, but results have varied, and these agents are still under development.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1267</p>",
      "correct_choice_id": 283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of medical treatment</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Fistula and abscess formation</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysplasia</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute exacerbation of disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not an indication for surgical therapy in treatment of  Crohn's disease?</span></p>",
      "unique_key": "DT1189702",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189702,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Surgical treatment.</strong></p>\r\n<ul>\r\n<li>Although medical management is indicated during acute exacerbations of disease, <strong>most patients with chronic Crohn disease will require surgery </strong>at some time during the course of their illness.</li>\r\n<li>The goals are to preserve bowel length while minimizing postoperative complications and disease recurrence</li>\r\n<li>Approximately 70% of patients will require surgical resection within 15 years after diagnosis</li>\r\n<li>Indications for surgery include <strong>failure of medical treatment, bowel obstruction, fistula or abscess formation, steroid dependence, dysplasia or milgnancy</strong></li>\r\n<li>Most patients can be treated with elective surgery, especially with the improvement of medical management in the past decade. However, patients with intestinal perforation, peritonitis, excessive bleeding, or toxic megacolon require urgent surgery</li>\r\n<li>Children with Crohn disease and resulting systemic symptoms, such as growth retardation, may benefit from resection. The extraintestinal complications of Crohn disease, although not primary indications for operation, often subside after resection of the involved bowel; exceptions are that problems may continue with ankylosing spondylitis and hepatic complications</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1267</p>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">Heineke Mikulicz stricturoplasty</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">Finney's stricturoplasty</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Resection and anastomosis</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">Side-to-side isoperistaltic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the treatment of choice for stricture in Crohn's disease?</span></p>",
      "unique_key": "DT1189711",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Stricturing disease.</em></strong></p>\r\n<ul>\r\n<li>Intestinal obstruction is the most common indication for surgical therapy in patients with Crohn disease.</li>\r\n<li>Obstruction in these patients is often partial, and nonoperative management is initially The success of nonoperative management can often be predicted on the basis of the chronicity of symptoms at the affected site.</li>\r\n<li>In patients for whom it is difficult to determine whether the site of obstruction is caused by an acute exacerbation or a chronically strictured segment, <strong>stool lactoferrin and calprotectin levels </strong>may help identify acute inflammation, whereas certain genetic markers (e.g., <em>NOD2</em>, <em>TLR4</em>, <em>CX- 3CR1</em>) may predict potential success of medical therapy.</li>\r\n<li>In case of a chronic strictured segment, medical therapy is rarely Operative intervention is required for patients with complete obstruction and partial obstruction whose condition does not resolve with nonoperative management.</li>\r\n<li>The <strong>treatment of choice for intestinal obstruction </strong>in patients with Crohn disease is <strong>segmental resection of the involved segment with primary reanastomosis. </strong>This may involve segmental resection and primary anastomosis of a short segment of ileum or an ileocecectomy if both the ileum and cecum are involved.</li>\r\n<li><strong>In selected patients with obstruction caused by strictures </strong>(single or multiple), one option is to perform a <strong>strictureplasty </strong>that effectively widens the lumen but avoids intestinal resection.</li>\r\n<li>Strictureplasty is performed by making a longitudinal incision through the narrowed area of the intestine, followed by closure in a transverse fashion in a manner similar to that for a <strong>Heineke-Mikulicz pyloroplasty</strong>. For longer diseased segments (&gt;10 cm), the strictureplasty can be performed similar to a <strong>Finney pyloroplasty </strong>or a <strong>side-to- side isoperistaltic strictureplasty</strong>.</li>\r\n<li>Strictureplasty is best used in those patients with multiple short areas of narrowing present over long segments of intestine, in those who have already had several previous resections of the small intestine, and in those with chronic fibrous obstruction.</li>\r\n<li>This procedure preserves intestine and is associated with complication and recurrence rates comparable to those of resection and reanastomosis.</li>\r\n<li>Given the concerns for development of carcinoma at chronically strictured segments, full-thickness biopsy with frozen section of the stricture site has been advocated at the time of surgery to rule out malignant disease before strictureplasty is performed.</li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1268</p>",
      "correct_choice_id": 303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Intestinal perforation</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemorrhagic strictures</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Short segment stricture</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Fistula or abscess formation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not the contraindication to stricturoplasty?</span></p>",
      "unique_key": "DT1189714",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189714,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;  \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403252d10568d-0d91-417c-8929-0e922140310b.jpg\"><p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1269</p>",
      "correct_choice_id": 313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Thromboembolic complication</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Sepsis</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrointestinal cancer</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrolyte imbalance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is the leading cause of disease related death in a patient of Crohn's disease?</span></p>",
      "unique_key": "DT1189716",
      "question_audio": null,
      "question_video": null,
      "map_id": 1189716,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Standardized mortality rates in patients with Crohn disease show an increase in those whose disease began before the age of 20 years and in those who have had disease for longer than 13 years.</li>\r\n<li>Long-term survival studies suggest that patients with Crohn disease have a death rate approximately two to three times higher than that of the general population, which is most commonly related to chronic wound complications and sepsis</li>\r\n<li><strong>Gastrointestinal cancer remains the leading cause of disease-related deaths in patients with Crohn disease; </strong>other causes of disease-related deaths include <strong>sepsis, thromboembolic complications, and electrolyte disorders.</strong></li>\r\n</ul>\r\n<p><strong>Reference</strong>: Sabiston textbook of Surgery, chapter: 50, Edition: 21<sup>st</sup>, Pg: 1271</p>",
      "correct_choice_id": 323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}